|
|
 |
| |
| Home > About Us |
| |
|
|
| |
| Tissue Regeneration Therapeutics
Inc. (TRT), developing stem cells for
therapeutic applications in regenerative
medicine |
| |
| Founded in February of 2004, TRT
is committed to uncompromised protection of
human life by providing stem cell therapy
solutions that are generated from umbilical cord
tissue, thereby providing an alternative to
embryonic stem cells. |
| |
| TRT is a Canadian Controlled
Private Corporation (CCPC) life sciences company
founded on the research and intellectual
property of Dr. John E. Davies and his research
team at the Institute for Biomaterials and
Biomedical Engineering, University of Toronto (U
of T). |
| |
|
| |
| Stem Cell
Therapy: Development of HUCPVC
Therapy, a source of non-embryonic stem
cells for patient care |
| |
| Stem Cell
Banking: HUCPVC Storage for
the long-term storage of patient Umbilical Cord
Tissue stem cells collected after the full term
birth of your child |
| |
| Bone Augmentation:
Assisting the natural renewal and remodeling of
missing or broken bone with
OsteoScaf, our macroporous
biodegradable
scaffold | |
|
 | |
| |
| |
Founded February 2004
Canadian
Controlled Private Corporation (CCPC) life sciences
company |
| |
| Management: Dr. John E. Davies,
President; Dr.Ezra Lwowski, V.P. Finance |
| |
| | |
| |
